Skip to main content
Glama

Clinical trials search: ClinicalTrials.gov studies

gov_clinical_trials
Read-only

Search ClinicalTrials.gov studies by condition, intervention or any words, optionally only recruiting ones: NCT id, title, status, phase, conditions, interventions, sponsor, enrollment, start and completion dates, number of locations and countries, and a link. From the ClinicalTrials.gov API (US National Library of Medicine). Information only, not medical advice. Use to find trials for a condition or drug. Example: condition=type 1 diabetes. Price $0.01/call via x402 USDC or a card key (/credits), first 25 free; failed calls free. Reads or computes only and changes nothing; each call is charged, so repeats are not free.

Input Schema

NameRequiredDescriptionDefault
qNoAny other words (optional)
limitNoStudies to return, 1-20 (default 10)
statusNorecruiting, active, completed or all (default recruiting)
conditionNoCondition or disease, e.g. type 1 diabetes
interventionNoDrug or intervention, e.g. semaglutide (optional)

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover read-only, open-world, non-destructive and non-idempotent; the description adds real context on top: the source (NLM API), a returned-field inventory, a non-medical-advice disclaimer, and cost behaviour ('first 25 free; failed calls free... repeats are not free') that concretely explains why idempotentHint is false. It does not contradict any annotation, though it omits rate limits or result-cap behaviour for a broad query.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Purpose and scope are front-loaded in the first clause, with the returned-field list and the pricing/disclaimer tail after. Almost every sentence carries information an agent needs, though the payment and 'repeats are not free' lines are somewhat verbose for what they convey.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, and the description compensates by enumerating the returned fields (NCT id, title, status, phase, conditions, interventions, sponsor, enrollment, dates, location/country counts, link). With the safety profile in annotations and full parameter docs in the schema, an agent has everything needed to call this correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents all five parameters including defaults and ranges. The description only lightly echoes them ('by condition, intervention or any words', 'optionally only recruiting ones') and adds no format or syntax guidance beyond the schema. Baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource ('Search ClinicalTrials.gov studies') plus the three axes it searches by (condition, intervention, any words) and a default filter ('optionally only recruiting ones'). No sibling tool overlaps this domain, so disambiguation is trivially satisfied and the scope is unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use to find trials for a condition or drug' and gives a concrete invocation example ('condition=type 1 diabetes'), which tells the agent the intended call shape. No when-not-to-use or alternative is named, but there is no sibling to route to, so the gap is minor.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.